-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Introduction: Type 2 diabetes (T2D) is one of the most widespread epidemics in the world in the 21st century, type 2 diabetes is the basis of the increasing public health burden, there is a wealth of evidence that type 2 diabetes is associated with cognitive impairment, which can lead to cognitive decline and increase the risk of dementiaA study published May 14 in the journal Stroke found that people with type 2 diabetes had poorer cognitive abilities for 3-6 months after a stroke than those with normal fasting blood sugara new study published May 14 in the American Stroke Association, a journal of the American Heart Association, shows that people with type 2 diabetes, not those with prediabetes, have lower cognitive abilities for 3-6 months after a stroke than those with normal fasting blood sugar"Type 2 diabetes increases the risk of stroke and may increase the risk of dementia, which is why type 2 diabetes is another important goal in preventing dementia, and the focus should be on early stage treatment of diabetes, delaying or avoiding type 2 diabetes," said DrPerminder Sachdev, M.D., of the Centre for Brain Aging at the University of New South Wales Health Centre in Kensington, Sydney, Australia, and senior author of the studyin an earlier study,Sachidev and colleagues found that stroke patients with a history of type 2 diabetes had worse cognitive function than stroke patients without type 2 diabetes"In this study, it's important that we want to know if stroke patients with prediabetes have worse cognitive function than stroke patients without prediabetes, because prediabetes are so common that individuals may have several years of prediabetes before developing type 2 diabetes," said Sachidev, aEarly positive treatment of pre-diabetes can delay or prevent type 2 diabetesIf we treat pre-diabetes, will this prevent some people from developing dementia?researchers combined data from 1,601 stroke patients (average age 66; 63 percent male; 70 percent Asian; 26 percent white; 2.6 percent African-American) in one of seven international studies from six countriesAlmost all stroke patients have a blood clot-induced stroke and are assessed for various cognitive functions 3-6 months after the strokeThe detection and medical history of fasting blood glucose levels measured at the time of admission to the hospital is used to define type 2 diabetes and prediabetesthis study included the STROKOG study1People with type 2 diabetes scored significantly lower in different areas of cognitive function, including memory, attention, information processing speed, language, visual ability to reproduce or draw shapes or shapes or lines, mental flexibility and executive function, compared to patients with normal fasting blood sugar 2 Patients with prediabetes did not score significantly lower than those with normal blood sugar in any aspect of cognitive function after the researchers adjusted other factors, including stroke type, race, high blood pressure, smoking, past stroke, heart rhythm abnormalities, and body mass index, the comparison remained the same adjusted for age, gender, and education, the researchers found that deficiencies in all aspects of cognitive function highlighted the importance of assessing self-care capabilities in people with type 2 diabetes after stroke "We need to ensure that stroke patients are conscious and capable of dealing with complex and interwoven tasks, as well as to be able to effectively treat type 2 diabetes, including testing blood sugar levels multiple times a day, managing blood sugar monitoring devices, adjusting drug dosages, self-injecting insulin or other drugs, and understanding food labels and portion sizes to adjust what to eat and eat," said Jess Lo, senior research author of the study at the Sydney Centre for Healthy Brain Aging (cHeBA) in Kensington, New South Wales, Australia, and senior author of the study "
diabetes group, fasting blood glucose abnormality (IFG), and normal fasting blood glucose levels (FGL), said, "Although our study focused on post-stroke cognition, there is strong evidence that type 2 diabetes is associated with cognitive impairment." This is a very important message for the public Since our study has no evidence that prediabetes is associated with cognitive impairment, this underscores the importance of early diagnosis and treatment of prediabetes (often underdiagnosed) to delay or avoid developing type 2 diabetes "
the relationship between blood sugar status (diabetes, abnormal fasting blood sugar (IFG), normal fasting blood sugar) and cognitive function the limitation of this study is that there is no information about the duration and severity of diabetes, only based on blood sugar level measurements."